Synergy Pharma (SGYP) Adds to Gains as Analyst Stokes Speculation Fire

September 15, 2016 11:02 AM EDT

Find out which companies are about to raise their dividend well before the news hits the Street with's Dividend Insider Elite. Sign-up for a FREE trial here.

Synergy Pharma (NASDAQ: SGYP) is adding to recent gains after Citi highlighted the company as a biotech takeover target for Takeda yesterday. Share are up 8.5% after jumping 8.8% yesterday. Volume is running 4x normal.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Momentum Movers, Rumors, Trader Talk

Related Entities


Add Your Comment